European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
-
Eur J Vasc Endovasc Surg · Jul 2011
Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins.
To describe duplex ultrasound (DUS) outcomes 12 months following ultrasound-guided foam sclerotherapy (UGFS) of recurrent great saphenous varicose veins (GSVV). ⋯ A single session of UGFS can eradicate reflux in the AK and BK-GSV in over 93% of patients with symptomatic recurrent GSVV. Re-recurrence at 12 months is superior to that reported after redo GSV surgery, similar to that observed following other minimally-invasive techniques and, when it occurs, is effectively and simply treated by a single further session of UGFS.
-
Eur J Vasc Endovasc Surg · Jun 2011
Intra-abdominal hypertension and abdominal compartment syndrome after endovascular repair of ruptured abdominal aortic aneurysm.
To investigate the frequency of intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) after endovascular repair (EVAR) of ruptured abdominal aortic aneurysm (rAAA). ⋯ IAH and ACS are common and potential serious complications after EVAR for rAAA. Successful outcome depends on early recognition, early conservative treatment to reduce IAH and decompression laparotomy if ACS develops.
-
Eur J Vasc Endovasc Surg · Apr 2011
Patient-specific endovascular simulation influences interventionalists performing carotid artery stenting procedures.
The ability to perform patient-specific simulated rehearsal of complex endovascular interventions is a technological advance with potential benefits to patient outcomes. This study aimed to evaluate whether patient-specific rehearsal of a carotid artery stenting (CAS) procedure has an influence on tool selection and the use of fluoroscopy. ⋯ Patient-specific simulated rehearsal of a complex endovascular procedure strongly influences tool selection and fluoroscopy preferences for the real case. Further research has to evaluate how this technology may transfer from in vitro to in vivo and if it can reduce the radiation dose and the number of endovascular tools used and improve outcomes for patients in the clinical setting.